MedWatch

MSD Covid-19 treatment less effective than first thought

A new, larger patient study has found that the capsule treatment reduces hospitalizations and deaths associated with Covid-19 to a far lesser degree than previously documented.

Photo: MERCK & CO INC/VIA REUTERS / X80001

MSD's capsule-based treatment for Covid-19 is far less effective than originally thought.

A new, larger patient study reveals that the pill reduced hospitalizations and deaths associated with Covid-19 by 30 percent, compared to a previous 48 percent, Bloomberg News reports.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs